We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCraven House Capital Regulatory News (CRV)

Share Price Information for Craven House Capital (CRV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.20
Bid: 0.15
Ask: 0.25
Change: 0.00 (0.00%)
Spread: 0.10 (66.667%)
Open: 0.20
High: 0.20
Low: 0.20
Prev. Close: 0.20
CRV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Results

30 Jun 2008 07:00

RNS Number : 8069X
Medsea Estates Group PLC
30 June 2008
 



Medsea Estates Group PLC

PRELIMINARY RESULTS for the year ended 31st December 2007 

Chairman's Statement

Turnover rose 30% in the year to £10.5 million, but I regret to report that the Group recorded a loss before tax of £1.3 million. Clearly this was a very disappointing performance, but reflects the position we announced in our trading update in February. The Group's revenue in the second half of the year was only £4.6 million on a re-stated basis, a reflection not only of slowing activity, but also of the difficulties we have experienced as a result of our dependence on third parties to complete the sales processes in a timely manner.

The Board has taken the decision to change the Group's revenue recognition policy, so we are no longer taking into account income that is in the pipeline. Additionally, we have decided that the degree of influence Medsea now exercises over its investments is no longer sufficient in all cases to justify their inclusion as associates and accordingly certain investments have been reclassified as available for sale investments and profits will now be recognised when they crystallise rather than on the equity basis.

Basically, 2007 was characterised by two distinct halves: the first half of the year witnessed exceptionally strong sales growth for our Italian business as the attractiveness of properties in Calabria led to record sales of 608 units in the first half year. The unexpected complexity of operating in this market however led to cancellations and, most importantly commission collection delays in the second half of the year.

In general, our experience to date in the burgeoning Italian market has brought the following issues to light:

•  The process by which reservations are converted to firm, billable and collectable commissions has been generally hampered by regulatory and third party inefficiencies

•  Delays in Medsea receiving such commissions have resulted in a cash flow squeeze for both Medsea and its agents, with the latter resulting in a throttling of the new business pipeline

•  Costs related to the expansion in the Italian market impacted profitability in the second half of the year

The Group has focused heavily on easing the commission backlog and is hopeful that the use of its call centre and other initiatives will enable commissions to flow more readily in the coming months.

Quite clearly, recent events in the credit markets have placed pressure on the markets in which Medsea operates. Cancellations are often linked to financial pressures experienced by buyers. The Spanish market has been experiencing a downturn already for a number of years and market forces have created a buyer's market. Medsea is not immune to such developments and is continually right sizing the business to reflect these conditions. Nevertheless, the general trend of Northern Europeans seeking either a primary or secondary home in the Mediterranean has not ceased and reduced prices are likely to increase the attractiveness for new buyers.

As an AIM company, we notified in our interim results announcement that the Group is now required to report according to International Financial Reporting Standards. In fact, this change from UK GAAP has no material impact on our numbers, but we have taken the opportunity provided by this change to review the accounting policies that we were advised to implement when the Group was floated on AIM. 

The reality is that whilst the policy in relation to income recognition was absolutely proper, the alternative approach to which we have now changed provides a better measure of performance and where management should focus their attention. This change also has the advantage that our results will no longer be affected by actual cancellations being at different levels to cancellation provisions in our accounts as the latter will no longer be needed. An explanation of the impact of these changes is provided in the financial statements.

January 2008 started better than we had expected, but since then sales have continued to decline which has led the company to implement a series of cost-cutting measures. We believe this will enable us to emerge as a stronger Group once market conditions improve.

Tony Gatehouse

Chairman

  

Finance Review

Income Statement

Year on year increase in turnover to £10,537,000 represents an increase of 30% over the year 2006. Loss before tax has increased to £1,297,000 compared to a loss of £1,048,000 in the previous year.

Gross margins improved from 13.7% in 2006 to 21.5% in 2007, but this was off-set by an increase in administrative costs of £1,400,000.

The results for the year have been drawn up using a different income recognition policy to that hitherto. The basic effect is that only income that has been invoiced or is invoicable by the year end has been taken to the profit and loss account. This means that commissions that would have been receivable and payable under the previous policy have not been included in these accounts.

Due to external changes and the impact of the credit squeeze, the Group has reviewed the degree of influence it currently exercises in relation to its Associates. As a result the directors consider that the Group no longer exercises the appropriate influence in respect of two of the investments, and these have been re-classified as available for sale financial assets.

Earnings per share, basic and diluted, in the year are minus 1.76 pence compared to minus 1.67 pence in 2006.

Balance Sheet

There has been a significant increase in the sums invested in Associates, resulting from the matters referred to in note 26 of the 2006 accounts and in note 25 of these accounts. This has in turn resulted in the decrease in trade receivables as reported at the 2006 year end.

It is now expected that the profits from Associates will start to crystalise in 2009.

Cash Flow

The Group raised £735,000 through a share placing in June 2007.

The net cash outflow during the year in respect of operating activities reflects the impact of the loss recorded.

  

MEDSEA GROUP ESTATES PLC AND SUBSIDIARY UNDERTAKINGS

CONSOLIDATED INCOME STATEMENT

FOR THE YEAR ENDED 31 DECEMBER 2007

 

 

 

 

 

 

 

 

 

 

 

 

 

2007

2006

As restated

£'000

£'000

Revenue

10,537 

8,066 

Cost of sales

(8,274)

(6,963)

Administrative expenses

(3,556)

(2,121)

Finance income

24 

Finance expense

(28)

(31)

 

 

Loss before taxation

(1,297)

(1,048)

Tax (charge)/credit on loss

(14) 

(129)

 

 

Loss for the year

(1,311)

(1,177)

Attributable to:

Equity holders of the parent

Minority interests

(1,307) 

(4) 

(1,172) (5) 

 

 

(1,311)

(1,177)

Loss per share (pence)

Basic and diluted

(1.76)

(1.67)

None of the group´s activities was acquired or discontinued during the above periods.

  

CONSOLIDATED BALANCE SHEET

AS AT 31 DECEMBER 2007

2007

2006

As re-stated

£'000

£'000

ASSETS

Non-current assets

Other intangible assets

Property, plant and equipment

1,057 

871 

Investments in associates

646 

Other financial assets

100 

92 

1,807 

969 

Current assets

Inventories

165 

301 

Trade and other receivables 

1,788 

2,319 

Current tax recoverable

15 

-

Cash and cash equivalents

317 

944 

2,285 

3,564 

Total assets

4,092 

4,533 

EQUITY AND LIABILITIES

Shareholders' equity

Share capital

7,798 

7,063 

Share premium

22 

22 

Other reserve

128 

117 

Revaluation reserve

51 

46 

Merger reserve

(7,058)

(7,058)

Foreign currency translation reserve

(170)

(109)

Retained earnings

(475)

778 

Minority interests

-

296 

863 

Non-current liabilities

Long-term borrowings

209 

300 

Deferred tax

-

91 

209 

391 

Current liabilities

Trade and other payables

3,065 

3,031 

Short-term borrowings

522 

248 

3,587 

3,279 

Total equity and liabilities

4,092 

4,533

  

CONSOLIDATED STATEMENT OF CASH FLOWS

FOR THE YEAR ENDED 31 DECEMBER 2007

2007

2006

re-stated

£'000

£'000

Cash flows from operating activities

Profit/(loss) before tax

(1,297)

(1,048)

Adjustments for:

Depreciation

127 

121 

Foreign exchange 

(63)

(90)

Finance income

(24)

(1)

Finance expense

28 

31 

Amortisation of other intangible assets

Loss / (profit) on sale of property, plant and equipment

15 

(52)

Decrease / (increase) in trade and other receivables

548 

(477)

Decrease / (increase) in inventories

136 

(119)

Increase in trade and other payables

47 

2,246 

 

 

Cash (absorbed by) / generated from operations

(481)

614 

Tax on profits paid

(137) 

(164)

Interest paid

(28)

(31)

 

Net cash (absorbed by) / generated from operating activities

(647)

 

419 

Cash from investing activities

Interest received

24

Purchase of property, plant and equipment

(256)

(107)

Proceeds from the sale of property, plant and equipment

-

276 

Payments to acquire shares in associates

(654)

-

Payments to acquire other intangible assets

(1)

(7)

 

 

Net cash (used) / generated in investing activities

(887)

163 

Cash from financing activities

Receipt of borrowings

123 

352 

Share issues

735 

-

Other loans

(13)

(118)

Capital element of finance lease (payments)/receipts

(27)

55 

 

 

Net cash generated from financing activites

818 

289 

Net (decrease)/ increase in cash and cash equivalents

(715)

871 

Cash and cash equivalents at the beginning of the period

944 

73 

Cash and cash equivalents at the end of the period

229 

944 

Cash and cash equivalents consists of:

Cash and cash equivalents included in current assets

317

944

Bank overdraft included in current liabilities

(88)

-

229

944

  

1. Basis of preparation

The financial statements have been prepared under the historical cost convention, as modified by the revaluation of certain non-current assets and in accordance with applicable International Financial Reporting Standards (IFRS) as adopted for use by the European Union.

These are the Group's first IFRS consolidated financial statements. IFRS 1 'First-time adoption of International Financial Reporting Standards' has been applied. An explanation as to how the transition in respect of IFRS has affected the reported financial position, financial performance and cash flow of the group is provided below in the reconciliations of equity and profit or loss for the comparative periods reported under UK GAAP to those reported for those periods under IFRSs; the impact of the change in the accounting policy for income recognition is also explained.

The group financial statements consolidate Medsea Estates Group PLC and all its subsidiary undertakings drawn up to 31 December each year. Medsea Estates Group PLC acquired shares in Medsea UK Limited and its subsidiaries on 16 July 2004. The financial statements have been prepared using merger accounting so that all the combining entities' results are shown from 1 January 2004.

As this business combination occurred before the transition date to IFRS of 1 January 2006, the exemption from retrospective application of IFRS3 Business Combinations has been taken.

2. Operating loss

The operating loss is arrived at after charging:

2007

2006

 £'000 

 £'000 

Depreciation of owned assets

109 

111 

Depreciation of leased assets

18 

10 

Amortisation of intangible assets

Loss/(Profit) on disposal of property, plant and equipment

15 

(52)

Hire of equipment - operating leases - motor vehicles

655 

373 

Hire of equipment - operating leases - land and buildings

143 

174 

Auditors' remuneration - other services

27 

Auditors' remuneration - audit services

40 

31 

 
 
Share capital
 
Share premium
 
Other reserves *
 
Revaluation reserve
 
Merger reserve
 
Foreign Currency Translation Reserve
 
Retained earnings
 
Minority interests
 
Total Equity
 
 
£'000
 
£'000
 
£'000
 
£'000
 
£'000
 
£'000
 
£'000
 
£'000
 
£'000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at 1 January 2006
7,063
 
22
 
117
 
96
 
(7,058)
 
-
 
1,944
 
9
 
2,193
Loss for the year
-
 
-
 
-
 
-
 
-
 
-
 
(1,172)
 
-
 
(1,172)
Exchange differences arising on translation of foreign operations
-
 
-
 
-
 
(1)
 
-
 
(109)
 
(43)
 
-
 
(153)
Minority interest
-
 
-
 
-
 
-
 
-
 
-
 
-
 
(5)
 
(5)
Sales of revalued properties
-
 
-
 
-
 
(49)
 
-
 
-
 
49
 
-
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total recognised income and expense for the period
7,063
 
22
 
117
 
46
 
(7,058)
 
(109)
 
778
 
4
 
863
Payment of dividends
-
 
-
 
-
 
-
 
-
 
-
 
-
 
-
 
-
Balance at 31 December 2006 carried forward
7,063
 
22
 
117
 
46
 
(7,058)
 
(109)
 
778
 
4
 
863
Balance at 1 January 2007 brought forward
7,063
 
22
 
117
 
46
 
(7,058)
 
(109)
 
778
 
4
 
863
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loss for the period
-
 
-
 
-
 
-
 
-
 
-
 
(1,307)
 
-
 
(1,307)
Exchange differences arising on translation of foreign operations
-
 
-
 
11
 
5
 
-
 
(61)
 
54
 
-
 
9
Minority interest
 
 
 
 
-
 
-
 
-
 
-
 
-
 
(4)
 
(4)
Sales of revalued properties
-
 
-
 
-
 
-
 
-
 
-
 
-
 
-
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total recognised income and expense for the year
7,063
 
22
 
128
 
51
 
(7,058)
 
(170)
 
(475)
 
-
 
(439)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Issue of shares
735
 
-
 
-
 
-
 
-
 
-
 
-
 
-
 
735
Payment of dividends
-
 
-
 
-
 
-
 
-
 
-
 
-
 
-
 
-
Balance at 31 December 2007 carried forward
7,798
 
22
 
128
 
51
 
(7,058)
 
(170)
 
(475)
 
-
 
296

* Each company in the Group registered in Spain is required to transfer 10% of its profit each year to a non-distributable reserve until the balance on that reserve reaches 20% of that company's paid up share capital. This balance is reflected under other reserves and the reserve was fully funded at 31 December 2007

 

 

4. Explanation of transition to IFRS and change in Revenue Recognition Policy

The Group has applied IFRS1, First Time Adoption of International Financial Reporting Standards in preparing these consolidated financial statements. The Group's transition date is 1st January 2006 and as such an opening IFRS balance sheet has been prepared at that date. Consequently, 2006 comparative information has been restated under these new accounting standards.

IFRS 1 allows certain exemptions from full retrospective application of certain standards. In preparing these consolidated financial statements, the group has elected to apply the business combinations exemption in IFRS 1. Therefore, it has not restated the business combinations that took place prior to the 1 January 2006 transition date, which resulted in the creation of the merger reserve.

As part of adopting IFRS, the Directors have also decided to alter the accounting policy in respect of revenue recognition.

Hitherto commission income and the consequent commission payable have been accrued in full at the time that clients made payment of a non-refundable reservation deposit to the developer. To allow for subsequent cancellations, a cancellation provision was then made against these accruals in order to reduce the accrued income and expenditure in the accounts to levels that would be comparable with what was actually invoiced. Because of the sometimes protracted period between reservation and completion, establishing the correct level of cancellation provision has become increasingly difficult. Accordingly, the consolidated accounts will now report on commission receivable on the basis of whether it was invoiced or invoicable by the end of the accounting period concerned. This means that commission (both receivable and payable) is only being recognised if the client purchasers have paid the first full instalment on their property purchase (often 50% of the selling price) which then triggers the contractual arrangement whereby commission can be claimed from the developer

Due to external changes and the impact of the credit squeeze, the Group has reviewed the degree of influence it currently exercises in relation to its Associates. As a result the directors consider that the Group no longer exercises the appropriate influence in respect of two of the investments, and these have been re-classified as available for sale financial assets

  

5. Reconciliation of the consolidated income statement for the year ended 31 December 2006

Effect of 

Effect of 

change to

change to

Restated

Effect of

Restated

2006

status of

income 

2006

transition 

2006

UK GAAP

associates

recognition

UK GAAP

to IFRS

IFRS

£'000

£'000

£'000

£'000

£'000

£'000

Revenue

13,300

-

(5,234)

8,066

-

8,066

Cost of sales

(8,849)

-

1,886

(6,963)

-

(6,963)

Administrative expenses

(2,229)

-

108

(2,121)

-

(2,121)

Share of operating profit in associates

702

(702)

-

-

-

-

Finance income

1

-

-

1

-

1

Finance expense

(31)

-

-

(31)

-

(31)

Profit/(loss) before taxation

2,894

(702)

(3,240)

(1,048)

-

(1,048)

Tax (charge)/credit on loss

(1,019)

890

(129)

-

(129)

Profit/(loss) for the year

1,875

(702)

(2,350)

(1,177)

-

(1,177)

Attributable to:

Equity holders of the parent

1,880

(702)

(2,350)

(1,172)

-

(1,172)

Minority interests

(5)

-

-

(5)

-

(5)

Retained profit/(loss) for the year

1,875

(702)

(2,350)

(1,177)

-

(1,177)

Earnings/(loss) per share (pence)

Basic and diluted

2.66 

(1.67)

(1.67)

6. Reconciliation of consolidated equity at 31 December 2006 (last date of UK GAAP statements)

Effect of 

Effect of 

change to

change to

Restated

Effect of

Restated

2006

status of

income 

2006

transition 

2006

UK GAAP

associates

recognition

UK GAAP

to IFRS

IFRS

£'000

£'000

£'000

£'000

£'000

£'000

ASSETS

Non-current assets

Other intangible assets

6

-

-

6

-

6

Property, plant and equipment

871

-

-

871

-

871

Investments in associates

687

(687)

-

-

-

-

Other financial assets

-

92

-

92

-

92

1,564

(595)

-

969

-

969

Current assets

Inventories

301

-

-

301

-

301

Trade and other receivables 

12,245

-

(9,926)

2,319

-

2,319

Cash and cash equivalents

944

-

-

944

-

944

13,490

-

(9,926)

3,564

-

3,564

Total assets

15,054

(595)

(9,926)

4,533

-

4,533

EQUITY AND LIABILITIES

Shareholders' equity

Share capital

7,063

-

-

7,063

-

7,063

Share premium

22

-

-

22

-

22

Other reserve

117

-

-

117

-

117

Revaluation reserve

46

-

-

46

-

46

Merger reserve

(7,058)

-

-

(7,058)

-

(7,058)

Foreign currency translation reserve

-

-

-

0

(109)

(109)

Retained earnings

5,446

(595)

(4,182)

669

109 

778

Minority interests

4

-

-

4

-

4

5,640

(595)

(4,182)

863

-

863

Non-current liabilities

Long-term borrowings

300

-

-

300

-

300

Deferred tax

1,535

-

(1,444)

91

-

91

1,835

-

(1,444)

391

-

391

Current liabilities

Trade and other payables

7,331

-

(4,300)

3,031

-

3,031

Short-term borrowings

248

-

-

248

-

248

Current tax payable

-

-

-

-

-

-

7,579

-

(4,300)

3,279

-

3,279

Total equity and liabilities

15,054

(595)

(9,962)

4,533

-

4,533

  

Re-statement of Interim results as at 30 June 2007

These numbers are unaudited and do not form part of the financial statements for the year 2007. They are furnished for information purposes.

UNAUDITED CONSOLIDATED INCOME STATEMENT 

AS AT 30 JUNE 2007

Group reconciliation of profit for the 6 months to 30 June 2007

Unaudited

Unaudited

Unaudited

Unaudited

Original

Effect of

Effect of 

Restated

30 June

change to 

change to

30 June

2007

status of

Income 

2007

associates

Recognition

£'000

£'000

£'000

£'000

Revenue

5,515

-

406

5,921

Cost of sales

(4,278)

-

(116)

(4,394)

Administrative expenses

(1,395)

-

(11)

(1,406)

Share of operating profit in associates

226

(226)

(226)

-

Finance income

4

-

0

4

Finance expense

(14)

-

-

(14)

Profit/(loss) before taxation

58

(226)

53

111

Tax on profit/(loss) 

(35) 

-

(50)

(15)

Profit/(loss) after taxation

93 

(226)

96 

  

UNAUDITED CONSOLIDATED BALANCE SHEET 

Group reconciliation of equity at 30 June 2007

Unaudited

Unaudited

Unaudited

Unaudited

Original

Effect of 

Effect of 

Restated

30 June

change to

change to

30 June

2007

status of

Income 

2007

associates

Recognition

£'000

£'000

£'000

£'000

Non-current assets

Other intangible assets

6

-

-

6

Property, plant and equipment

962

-

-

962

Investments in associates

1,064

(839)

(747)

317

Other financial assets

0

92

-

92

2,032

(747)

(747)

1,285

Current assets

Inventories

192

-

-

192

Trade and other receivables 

11,691

(9,553)

2,138

Cash and cash equivalents

1,672

-

-

1,672

13,555

-

(9,553)

4,002

Total assets

15,587

(747)

(10,300)

5,287

Shareholders' equity

Share capital

7,798

-

-

7,798

Share premium

22

-

-

22

Other reserve

117

-

-

117

Revaluation reserve

46

-

-

46

Merger reserve

(7,058)

-

-

(7,058)

Retained earnings

5,489

(747)

(4,658)

831

Minority interests

(1)

-

-

(1)

6,413

(747)

(4,658)

1,755

Non-current liabilities

Long-term borrowings

249

-

-

249

Deferred tax

1,328

(1,325)

1,577

-

(1,325)

252

Current liabilities

Trade and other payables

7,460

(4,317)

3,143

Short-term borrowings

137

-

-

137

7,597

-

(4,317)

3,280

Total equity and liabilities

15,587

(747)

(10,300)

5,287

  

Publication of non-statutory accounts 

The financial information set out in this preliminary announcement does not constitute statutory accounts as defined in Section 240 of the Companies Act 1985. Statutory accounts for 2007 will be delivered to the Registrar following the Company's Annual General Meeting. 

The Independent Auditors have reported on these accounts. Their report was unqualified and did not contain statements under section 237(2) or (3) of the Companies Act 1985. 

Other information 

The report and accounts for the year ended 31 December 2007 will be posted to shareholders shortly and laid before the Group's Annual General Meeting.

Copies will also be available via the website (www. www.medseaestates-ir.com) in accordance with AIM Rule 26 and at the Company's registered office, Medsea Estates Group PLC, 85 Elsenham StreetLondonSW18 5NX.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FR SEDEFUSASEDM
Date   Source Headline
28th Feb 20247:00 amRNSInterim Results
4th Jan 20247:00 amRNSResult of Annual General Meeting
29th Nov 20232:48 pmRNSAnnual Results for year ended 31 May 2023
28th Nov 20234:08 pmRNSInvestee Companies' Update
16th Nov 20239:07 amRNSInvestee Companies’ Update: Garimon and Honeydog
23rd Oct 20237:00 amRNSInvestee company update: Bio Vitos
17th Oct 20237:46 amRNSInvestee Companies’ Update: Garimon and Honeydog
29th Aug 20231:34 pmRNSInvestee company update: Bio Vitos
3rd Jul 20231:32 pmRNSInvestee company update: Bio Vitos
3rd Mar 20236:15 pmRNSPortfolio Update
27th Feb 20233:30 pmRNSInterim Results
8th Feb 20237:00 amRNSInvestee company update: Bio Vitos
27th Jan 202311:33 amRNSResult of Annual General Meeting
29th Nov 20227:00 amRNSAnnual Results for Year Ended 31 May 2022
15th Nov 20222:42 pmRNSInvestee company update: Garimon Ltd
23rd Feb 20223:01 pmRNSInterim Results
21st Jan 202212:45 pmRNSResult of AGM
23rd Dec 20213:59 pmRNSNotice of AGM
29th Nov 20216:29 pmRNSAnnual Results for year ended 31 May 2021
24th Nov 20212:55 pmRNSInvestee company update: OneBas.Com Ltd.
26th Oct 20217:00 amRNSInvestee company update: YRRO Ltd
16th Mar 20211:06 pmRNSTR-1: Notification of major holdings
18th Feb 20213:07 pmRNSInterim Results
11th Feb 202111:21 amRNSTR-1: Notification of major holdings
5th Feb 202110:44 amRNSStatement Regarding Share Price Movement
18th Jan 20212:49 pmRNSResult of Annual General Meeting
21st Dec 20207:00 amRNSNotice of General Meeting
9th Dec 20207:00 amRNSInvestee Company Update: YRRO Ltd
3rd Dec 202012:43 pmRNSAnnual Results for year ended 31 May 2020
9th Nov 20209:45 amRNSChange of Auditor
9th Oct 20203:14 pmRNSTrading Update, Change of Auditor & 2020 Results
18th Sep 202010:57 amRNSInvestee company update: Magazinos.com
22nd Jun 20201:01 pmRNSTR-1: Notification of major holdings
18th Jun 202011:06 amRNSSecond Price Monitoring Extn
18th Jun 202011:00 amRNSPrice Monitoring Extension
3rd Jun 20201:27 pmRNSTR-1: Notification of major holdings
1st Jun 20202:05 pmRNSSecond Price Monitoring Extn
1st Jun 20202:00 pmRNSPrice Monitoring Extension
22nd May 20209:43 amRNSResult of General Meeting
5th May 202010:42 amRNSTR-1: Notification of major holdings
1st May 202010:58 amRNSPosting of Circular
1st Apr 20203:39 pmRNSCoronavirus and Business Update
23rd Mar 202012:19 pmRNSOn-line Platform Launched by Investee, Rosedog Ltd
20th Mar 20205:01 pmRNSNotification of major holdings
13th Mar 20207:00 amRNSSimultaneous exercise of five Option Agreements
27th Feb 202011:22 amRNSIssue of Equity and Directors' Dealing
27th Feb 20207:00 amRNSInterim Results
25th Feb 20209:16 amRNSNotification of major holdings
24th Feb 20207:00 amRNSCraven House signs 5 Non-binding Option Agreements
18th Feb 20202:54 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.